Projects per year
Personal profile
Expertise related to UN SDGs
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
Dive into the research topics where Marco Pravetoni is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 2 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects and Grants
-
Adjuvanted Opioid Vaccine for Treating Fentanyl Use Disorder
Pravetoni, M. & Borgatti, A. M.
9/30/20 → 9/29/21
Project: Research project
-
Antibody-based countermeasures against fentanyl and its analogues
9/1/20 → 7/31/23
Project: Research project
-
Phase 1a/1b Clinical Trials of Multivalent Opioid Vaccine Components
Research Foundation for Mental Hygiene
9/1/19 → 8/31/21
Project: Research project
-
Novel nanovaccines against opioid use disorder
Pravetoni, M. & Birnbaum, A. K.
VIRGINIA POLYTECHNIC INST. & STATE UNIV.
7/15/19 → 6/30/21
Project: Research project
-
Development of TRAC-478: A Synthetic Dual TLR Adjuvant Combination System
7/1/19 → 6/30/21
Project: Research project
Research output
-
Combining a candidate vaccine for opioid use disorders with extended-release naltrexone increases protection against oxycodone-induced behavioral effects and toxicity
Raleigh, M. D., Accetturo, C. & Pravetoni, M., Sep 1 2020, In: Journal of Pharmacology and Experimental Therapeutics. 374, 3, p. 392-403 12 p.Research output: Contribution to journal › Article › peer-review
-
Countermeasures for Preventing and Treating Opioid Overdose
France, C. P., Ahern, G. P., Averick, S., Disney, A., Enright, H. A., Esmaeli-Azad, B., Federico, A., Gerak, L. R., Husbands, S. M., Kolber, B., Lau, E. Y., Lao, V., Maguire, D. R., Malfatti, M. A., Martinez, G., Mayer, B. P., Pravetoni, M., Sahibzada, N., Skolnick, P., Snyder, E. Y. & 3 others, , 2020, (Accepted/In press) In: Clinical pharmacology and therapeutics.Research output: Contribution to journal › Review article › peer-review
-
Interruption of continuous opioid exposure exacerbates drug-evoked adaptations in the mesolimbic dopamine system
Lefevre, E. M., Pisansky, M. T., Toddes, C., Baruffaldi, F., Pravetoni, M., Tian, L., Kono, T. J. Y. & Rothwell, P. E., Oct 1 2020, In: Neuropsychopharmacology. 45, 11, p. 1781-1792 12 p.Research output: Contribution to journal › Article › peer-review
Open Access4 Scopus citations -
Is the opioid use disorder epidemic impacting our immunological health?
Pravetoni, M., Jul 2020, In: Brain, Behavior, and Immunity. 87, p. 203-204 2 p.Research output: Contribution to journal › Comment/debate › peer-review
-
Mechanisms of interleukin 4 mediated increase in efficacy of vaccines against opioid use disorders
Crouse, B., Robinson, C., Huseby Kelcher, A., Laudenbach, M., Abrahante, J. E. & Pravetoni, M., Dec 1 2020, In: npj Vaccines. 5, 1, 99.Research output: Contribution to journal › Article › peer-review
Open Access
Press / Media
-
U of M researchers receive $2.4 million grant to develop fentanyl vaccines and antibodies
10/7/20
1 item of Media coverage
Press/Media: Research
-
U of M researchers working to develop vaccine for future coronavirus strains
Marco Pravetoni & Geoffrey T Hart
7/15/20
1 item of Media coverage
Press/Media: Expert Comment